证券记录 · 已归档季度
ANRO
Alto Neuroscience, Inc. · Healthcare · Biotechnology
12被追踪持有人
0Δ持有人
4.77M持有股份
$10.50M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -8.1% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | +2 | 11.55M | $304.50M | +10 | −8 |
| Q1 2026 | 55 | +7 | 8.39M | $188.63M | +8 | −1 |
| Q4 2025 | 48 | +2 | 8.42M | $149.83M | +3 | −1 |
| Q3 2025 | 15 | +1 | 4.77M | $19.16M | +1 | — |
| Q2 2025 | 12 | 0 | 4.77M | $10.50M | +1 | −1 |
| Q1 2025 | 9 | +1 | 3.54M | $7.65M | +2 | −1 |
| Q4 2024 | 8 | +2 | 5.27M | $22.30M | +2 | — |
| Q3 2024 | 5 | 0 | 2.33M | $26.66M | +2 | −2 |
| Q2 2024 | 5 | — | 1.98M | $21.15M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 1.33M | +7.2% | $2.93M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 2 | The Vanguard Group ✦ (被动) | 1.08M | — | $2.39M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (被动) | 1.08M | — | $2.39M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Marshall Wace ✦ | 937.41K | +9.9% | $2.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Marshall Wace ✦ | 937.41K | +9.9% | $2.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 561.85K | — | $1.24M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 561.85K | — | $1.24M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 561.85K | — | $1.24M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 561.85K | — | $1.24M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 561.85K | — | $1.24M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 561.85K | — | $1.24M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 302.86K | +1772.0% | $666,296 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Geode Capital Management ✦ (被动) | 229.72K | -52.8% | $505,641 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | Geode Capital Management ✦ (被动) | 229.72K | -52.8% | $505,641 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | State Street Global Advisors ✦ (被动) | 104.73K | -69.1% | $230,415 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 76.51K | +217.5% | $168,326 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 76.51K | +217.5% | $168,326 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 76.51K | +217.5% | $168,326 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 76.51K | +217.5% | $168,326 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 59.43K | +10.2% | $131,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 44.73K | +71.1% | $98,417 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | Renaissance Technologies ✦ | 34.70K | 新增 | $76,340 | 0.0% | New | 1 | SEC ↗ |
| 23 | Fidelity (FMR) ✦ | 8.30K | — | $18,253 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Renaissance Technologies | $76,340 | 0.0% |
已清仓
| Citadel Advisors | $1.08M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 108 持有人, 26.83M 股份, $592.78M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据